iPhone 6
ƒ/2.2
4.15 mm
1/30
40

Back in September 2015, we got a sneak peek into the news of today. Dan Gibson, one of the principle scientists presented the simplest life form on Earth to the SGI Board. It has an engineered genome of just 473 genes synthesized from base chemicals in the digital biological converter (DBC).

Congratulations to Ham Smith, Craig Venter, Clyde Hutchison, Dan Gibson and the collaborative teams across Synthetic Genomics and the Venter Institute on the debut of syn3.0.

I have been tracking this project with fascination for most of its 20 year history, nine of them at SGI. What an epic quest it has been! The dedication of the core team is incredible. While progress has been steady, with today’s publication in Science, the world can wish you a hearty: C O N G R A T U L A T I O N S !!!

P.S. Dan Gibson also invented what is called Gibson Assembly, which makes him a rock star!

www.forbes.com/sites/matthewherper/2016/03/24/bio-maveric…

www.syntheticgenomics.com/news20160324.html

9 responses to “Dan Gibson unveiling the simplest life form on Earth — SGI’s Synthia — with just 473 genes”

  1. syn3.0 clusterCell Syn 3
    Defragging the genome…. evolution is not the epitome of engineering efficiency. Defrag Of the 473 genes here, 79 have no understood function, but appear to be necessary for life in the organism. Of the rest, the genes fall into four major function groups: Gene expression (41%), cell membrane (18%), cytosolic metabolism (17%), and genome preservation (7%).Pie chartI took a look online, and I have been eagerly awaiting this day for over a decade… With Craig VenterCraig Venter and a blog post from 2004. And here is Craig Venter in 2010, when he saw the first colony pics of syn1.0Proud Papa gazes on his creationMore of my Craig Venter photos.

  2. this is so fascinating.

  3. Is there a specific commercial advantage to this instead of for example just putting the genes you want into E. Cold or something like that? I think that’s commonly done for chemical production or bio cleanup.

  4. P.s. … You turned on comments?

  5. Yes… I had them turned off for almost a year due to a persistent spammer/stalker. It’s good to be back. Yes, other host organisms are commonly used today. If you want to study the minimal form of life, with the least complexity of possible metabolic interactions, or if you want to synthesis an organism from the ground up, it helps to have a tiny base genome.

    For the simple microbes, there is a simple one-gene to one-protein mapping, lacking the vast regulatory regime of our nested genome. Looking at where they were able to delete genes (bottom of the list of Table 1 ), they reduced its dietary range to just glucose, removed DNA defenses, and removed a number of membrane transport proteins.

    And here is a video of syn3.0 growth.

  6. The Blob 2. This could be a line from the script: "Of the 473 genes, 79 have no understood function, but appear to be necessary for life in the organism." Hehheh

  7. Thanks [https://www.flickr.com/photos/jurvetson/]. What excites me is understanding the genes that appear to be necessary but whose function is as yet unknown. It could lead to huge advances in our understanding of the fundamentals of life on Earth, obviously with huge potential for advances in medicine.

  8. And now, Gibson’s latest paper on the The Digital-to-Biological Converter (DBC), or "life printer", just came out in Nature Biotech.

    Opening: "DNA templates, RNA molecules, proteins and viral particles were produced in an automated fashion from digitally transmitted DNA sequences without human intervention."

    Highlights: "First, we synthesized a 1.5-kb DNA fragment encoding GFP."
    "We next synthesized Orencia (abatacept), Lucentis (ranibizumab) and Herceptin (trastuzumab) antibody polypeptides"
    "We next applied the DBC to produce an RNA vaccine and a bacteriophage, both of which have potential as therapeutics for infectious diseases."
    "We also produced functional influenza viral particles (H1N1)"
    "Finally, we fully automated production of the ΦX174 bacteriophage, which has a 5,386-bp genome, on the DBC. The genome sequence was manually designed in silico"
    "with the incorporation of large-scale synthesis technologies, one can envision the DBC being used in industrial settings to enable high- volume production of biologics such as proteins and RNA vaccines."

    Summary release from SGI.

Leave a Reply

Your email address will not be published. Required fields are marked *